multitargeted antifolate ly231514 Search Results


multitarget antifolate  (MultiTarget Pharmaceuticals)
90
MultiTarget Pharmaceuticals multitarget antifolate
<t> Gemcitabine </t> monotherapy versus fluorouracil monotherapy for non-resectable (locally advanced or advanced) pancreatic cancer
Multitarget Antifolate, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multitargeted+antifolate+ly231514/multitarget+antifolate/pmc02907593-170-5-13
Average 90 stars, based on 1 article reviews
multitarget antifolate - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
ly231514  (MultiTarget Pharmaceuticals)
90
MultiTarget Pharmaceuticals ly231514
<t> Gemcitabine </t> monotherapy versus fluorouracil monotherapy for non-resectable (locally advanced or advanced) pancreatic cancer
Ly231514, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multitargeted+antifolate+ly231514/nt157/pm11514832-89-0-4
Average 90 stars, based on 1 article reviews
ly231514 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
pemetrexed  (MultiTarget Pharmaceuticals)
90
MultiTarget Pharmaceuticals pemetrexed
Anticancer chemotherapy-related severe cutaneous adverse drug reactions from the English literature (year: 1950–2017).
Pemetrexed, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multitargeted+antifolate+ly231514/pemetrexed/pmc05822766-20-0-2
Average 90 stars, based on 1 article reviews
pemetrexed - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
cmt-3 (col-3, metastat)  (MetaStat Inc)
90
MetaStat Inc cmt-3 (col-3, metastat)
Anticancer chemotherapy-related severe cutaneous adverse drug reactions from the English literature (year: 1950–2017).
Cmt 3 (Col 3, Metastat), supplied by MetaStat Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multitargeted+antifolate+ly231514/cmt+3/us07348003-2866-63-65
Average 90 stars, based on 1 article reviews
cmt-3 (col-3, metastat) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
abx-egf antibody  (ImmunoGen Inc)
90
ImmunoGen Inc abx-egf antibody
Anticancer chemotherapy-related severe cutaneous adverse drug reactions from the English literature (year: 1950–2017).
Abx Egf Antibody, supplied by ImmunoGen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multitargeted+antifolate+ly231514/abx+egf+antibody/us07402312-3003-33-82
Average 90 stars, based on 1 article reviews
abx-egf antibody - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
abx-egf  (ImmunoGen Inc)
90
ImmunoGen Inc abx-egf
Anticancer chemotherapy-related severe cutaneous adverse drug reactions from the English literature (year: 1950–2017).
Abx Egf, supplied by ImmunoGen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multitargeted+antifolate+ly231514/abx+egf/us07361341-2930-30-79
Average 90 stars, based on 1 article reviews
abx-egf - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
multitargeted antifolate mta  (AstraZeneca ltd)
90
AstraZeneca ltd multitargeted antifolate mta
Anticancer chemotherapy-related severe cutaneous adverse drug reactions from the English literature (year: 1950–2017).
Multitargeted Antifolate Mta, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multitargeted+antifolate+ly231514/multitargeted+antifolate+mta/pm12057154-67-11-7
Average 90 stars, based on 1 article reviews
multitargeted antifolate mta - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
phenylmethylsulfonyl fluoride  (Enamine Ltd)
99
Enamine Ltd phenylmethylsulfonyl fluoride
Anticancer chemotherapy-related severe cutaneous adverse drug reactions from the English literature (year: 1950–2017).
Phenylmethylsulfonyl Fluoride, supplied by Enamine Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multitargeted+antifolate+ly231514/Phenylmethylsulfonyl+fluoride/custom%40en300-24380%4011384244
Average 99 stars, based on 1 article reviews
phenylmethylsulfonyl fluoride - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

Image Search Results


Gemcitabine monotherapy versus fluorouracil monotherapy for non-resectable (locally advanced or advanced) pancreatic cancer

Journal: Clinical Evidence

Article Title: Pancreatic cancer

doi:

Figure Lengend Snippet: Gemcitabine monotherapy versus fluorouracil monotherapy for non-resectable (locally advanced or advanced) pancreatic cancer

Article Snippet: , , Subgroup analysis , Gemcitabine monotherapy v gemcitabine plus other cytotoxic agent (multitarget antifolate, pemetrexed, or topoisomerase inhibitors irinotecan or exatecan) , Overall survival: 4 RCTs, 1404 people; HR 0.99; P = 0.80; no further data reported.

Techniques:

Gemcitabine monotherapy versus gemcitabine-based combinations for non-resectable (locally advanced or advanced) pancreatic cancer

Journal: Clinical Evidence

Article Title: Pancreatic cancer

doi:

Figure Lengend Snippet: Gemcitabine monotherapy versus gemcitabine-based combinations for non-resectable (locally advanced or advanced) pancreatic cancer

Article Snippet: , , Subgroup analysis , Gemcitabine monotherapy v gemcitabine plus other cytotoxic agent (multitarget antifolate, pemetrexed, or topoisomerase inhibitors irinotecan or exatecan) , Overall survival: 4 RCTs, 1404 people; HR 0.99; P = 0.80; no further data reported.

Techniques:

Anticancer chemotherapy-related severe cutaneous adverse drug reactions from the English literature (year: 1950–2017).

Journal: Journal of Immunology Research

Article Title: Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies

doi: 10.1155/2018/5376476

Figure Lengend Snippet: Anticancer chemotherapy-related severe cutaneous adverse drug reactions from the English literature (year: 1950–2017).

Article Snippet: Pemetrexed , Multitarget antifolate , [ , ] , 2 , 0 , 0 , 0 , 2.

Techniques: